Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression
Engitix Therapeutics Collaboration leverages Engitix’s human ECM Platform to identify high-confidence targets for liver fibrosis regression LONDON, June…
#EuropeSays #Britain #Europe #EU #GSK #biotechnologycompany #developmentcapabilities #diseasemodels #ECM #ECMPlatform #EngitixLtd. #GiuseppeMazza #liverdisease #liverfibrosis #therapeutictargets
https://www.europesays.com/britain/81848/